Principal Financial Group Inc Ptc Therapeutics, Inc. Transaction History

Principal Financial Group Inc

  • $184 Billion
  • Q3 2025

A detailed history of Principal Financial Group Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 67,677 shares of PTCT stock, worth $5.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67,677
Previous 54,000 25.33%
Holding current value
$5.1 Million
Previous $2.64 Million 57.49%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025
BUY
$43.3 - $62.88 $592,214 - $860,009
13,677 Added 25.33%
67,677 $4.15 Million
Q2 2025

Aug 08, 2025
BUY
$36.19 - $52.13 $1.74 Million - $2.51 Million
48,160 Added 824.66%
54,000 $2.64 Million
Q1 2025

Apr 28, 2025
SELL
$41.81 - $57.17 $4,808 - $6,574
-115 Reduced 1.93%
5,840 $297,000
Q4 2024

Jan 31, 2025
BUY
$34.99 - $52.07 $208,365 - $310,076
5,955 New
5,955 $268,000
Q3 2024

Oct 31, 2024
SELL
$30.39 - $37.66 $171,581 - $212,628
-5,646 Reduced 45.82%
6,676 $247,000
Q2 2024

Jul 29, 2024
SELL
$24.69 - $40.12 $134,362 - $218,333
-5,442 Reduced 30.63%
12,322 $376,000
Q1 2024

Apr 29, 2024
BUY
$24.15 - $31.95 $7,003 - $9,265
290 Added 1.66%
17,764 $516,000
Q4 2023

Feb 07, 2024
SELL
$18.07 - $29.37 $2,710 - $4,405
-150 Reduced 0.85%
17,474 $481,000
Q3 2023

Nov 02, 2023
BUY
$22.41 - $41.99 $7,238 - $13,562
323 Added 1.87%
17,624 $394,000
Q2 2023

Aug 07, 2023
SELL
$40.4 - $59.1 $22,462 - $32,859
-556 Reduced 3.11%
17,301 $703,000
Q1 2023

May 09, 2023
SELL
$38.16 - $48.86 $8,089 - $10,358
-212 Reduced 1.17%
17,857 $864,000
Q4 2022

Feb 09, 2023
BUY
$33.53 - $54.79 $13,311 - $21,751
397 Added 2.25%
18,069 $689,000
Q3 2022

Nov 09, 2022
BUY
$41.85 - $53.85 $22,138 - $28,486
529 Added 3.09%
17,672 $887,000
Q2 2022

Aug 10, 2022
SELL
$25.6 - $45.23 $94,080 - $166,220
-3,675 Reduced 17.65%
17,143 $687,000
Q1 2022

May 09, 2022
BUY
$33.33 - $44.6 $18,098 - $24,217
543 Added 2.68%
20,818 $777,000
Q4 2021

Feb 09, 2022
SELL
$35.36 - $41.86 $306,217 - $362,507
-8,660 Reduced 29.93%
20,275 $807,000
Q3 2021

Nov 09, 2021
BUY
$37.01 - $44.74 $59,067 - $71,405
1,596 Added 5.84%
28,935 $1.08 Million
Q2 2021

Aug 10, 2021
SELL
$37.95 - $49.37 $33,775 - $43,939
-890 Reduced 3.15%
27,339 $1.16 Million
Q1 2021

May 10, 2021
SELL
$46.8 - $68.92 $65,707 - $96,763
-1,404 Reduced 4.74%
28,229 $1.34 Million
Q4 2020

Feb 08, 2021
BUY
$47.96 - $67.64 $346,558 - $488,766
7,226 Added 32.25%
29,633 $1.81 Million
Q3 2020

Nov 06, 2020
SELL
$45.41 - $57.07 $51,994 - $65,345
-1,145 Reduced 4.86%
22,407 $1.05 Million
Q2 2020

Aug 05, 2020
BUY
$42.56 - $54.98 $289,408 - $373,864
6,800 Added 40.59%
23,552 $1.2 Million
Q1 2020

May 12, 2020
BUY
$32.37 - $59.36 $21,558 - $39,533
666 Added 4.14%
16,752 $747,000
Q4 2019

Feb 05, 2020
SELL
$32.22 - $50.07 $49,103 - $76,306
-1,524 Reduced 8.65%
16,086 $772,000
Q3 2019

Nov 13, 2019
BUY
$33.82 - $48.17 $55,363 - $78,854
1,637 Added 10.25%
17,610 $596,000
Q2 2019

Aug 12, 2019
SELL
$35.42 - $45.0 $982,019 - $1.25 Million
-27,725 Reduced 63.45%
15,973 $718,000
Q1 2019

May 10, 2019
BUY
$28.09 - $39.49 $38,399 - $53,982
1,367 Added 3.23%
43,698 $1.65 Million
Q4 2018

Feb 14, 2019
BUY
$29.83 - $46.51 $69,533 - $108,414
2,331 Added 5.83%
42,331 $1.45 Million
Q3 2018

Nov 14, 2018
BUY
$33.9 - $47.77 $113,700 - $160,220
3,354 Added 9.15%
40,000 $1.88 Million
Q2 2018

Aug 13, 2018
BUY
$25.7 - $47.88 $217,807 - $405,783
8,475 Added 30.08%
36,646 $0
Q1 2018

May 14, 2018
BUY
$17.46 - $32.59 $64,671 - $120,713
3,704 Added 15.14%
28,171 $762,000
Q4 2017

Feb 13, 2018
BUY
$15.14 - $20.89 $370,430 - $511,115
24,467
24,467 $408,000

Others Institutions Holding PTCT

# of Institutions
332
Shares Held
84M
Call Options Held
810K
Put Options Held
207K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $5.39B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email